메뉴 건너뛰기




Volumn 13, Issue 9, 2014, Pages 1107-1114

Neonatal pertussis, cocooning and maternal immunization

Author keywords

cocooning; neonatal; pertussis; Tdap; vaccine

Indexed keywords

PERTUSSIS VACCINE; BACTERIUM ANTIBODY;

EID: 84905980767     PISSN: 14760584     EISSN: 17448395     Source Type: Journal    
DOI: 10.1586/14760584.2014.944509     Document Type: Review
Times cited : (45)

References (71)
  • 1
    • 0003564810 scopus 로고    scopus 로고
    • Pertussis (Whooping Cough). Atlanta, GA: CDC/Outbreaks. Available from [Last accessed 28 March 2013]
    • Pertussis (Whooping Cough). Centers for Disease Control and Prevention. Atlanta, GA: CDC/Outbreaks. Available from: www.cdc.gov/pertussis/outbreaks/ index.html [Last accessed 28 March 2013]
    • Centers for Disease Control and Prevention
  • 2
    • 0003564810 scopus 로고    scopus 로고
    • Provisional Pertussis Surveillance Report Atlanta, GA: CDC. Available from [Last accessed 3 January 2014]
    • Provisional Pertussis Surveillance Report. Centers for Disease Control and Prevention. Atlanta, GA: CDC. Available from: www.cdc.gov/pertussis/ downloads/pertussissurveillance-report.pdf [Last accessed 3 January 2014]
    • Centers for Disease Control and Prevention
  • 3
    • 0003564810 scopus 로고    scopus 로고
    • Final Pertussis Surveillance Report Atlanta, GA: CDC. Available from: [Last accessed 23 August 2013]
    • Final Pertussis Surveillance Report. Centers for Disease Control and Prevention. Atlanta, GA: CDC. Available from: www.cdc.gov/pertussis/downloads/ pertuss-surv-report-2012.pdf [Last accessed 23 August 2013]
    • Centers for Disease Control and Prevention
  • 4
    • 84905965331 scopus 로고    scopus 로고
    • World Health Organization, Geneva, Switzerland. Available from [Last accessed 1 Dec 2013]
    • Pertussis. World Health Organization, Geneva, Switzerland. Available from: www. cdc.gov/pertussis/outbreaks/index.html [Last accessed 1 Dec 2013]
    • Pertussis
  • 5
    • 24944492321 scopus 로고    scopus 로고
    • The epidemiology of pertussis: A comparison of the epidemiology of the disease pertussis with the epidemiology of Bordetella pertussis infection
    • DOI 10.1542/peds.2004-2648
    • Cherry JD. The epidemiology of pertussis: a comparison of the epidemiology of the disease pertussis with the epidemiology of Bordetella pertussis infection. Pediatrics 2005;115(5):1422-7 (Pubitemid 43852794)
    • (2005) Pediatrics , vol.115 , Issue.5 , pp. 1422-1427
    • Cherry, J.D.1
  • 6
    • 84865404858 scopus 로고    scopus 로고
    • Increase in pertussis may be due to increased recognition and diagnosis
    • Jenkinson D. Increase in pertussis may be due to increased recognition and diagnosis. BMJ 2012;345:e5463
    • (2012) BMJ , vol.345
    • Jenkinson, D.1
  • 7
    • 18744407870 scopus 로고    scopus 로고
    • Duration of immunity against pertussis after natural infection or vaccination
    • DOI 10.1097/01.inf.0000160914.59160.41
    • Wendelboe AM, Van Rie A, Salmaso S, Englund JA. Duration of immunity against pertussis after natural infection or vaccination. Pediatr Infect Dis J 2005; 24(5 Suppl):S58-61 (Pubitemid 40676539)
    • (2005) Pediatric Infectious Disease Journal , vol.24 , Issue.5
    • Wendelboe, A.M.1    Van Rie, A.2    Salmaso, S.3    Englund, J.A.4
  • 8
    • 0035212392 scopus 로고    scopus 로고
    • Polymorphism of Bordetella pertussis isolates circulating for the last 10 years in France, where a single effective whole-cell vaccine has been used for more than 30 years
    • DOI 10.1128/JCM.39.12.4396-4403.2001
    • Weber C, Boursaux-Eude C, Coralie G, et al. Polymorphism of Bordetella pertussis isolates circulating for the last 10 years in France, where a single effective whole-cell vaccine has been used for more than 30 years. J Clin Microbiol 2001;39(12): 4396-403 (Pubitemid 33117129)
    • (2001) Journal of Clinical Microbiology , vol.39 , Issue.12 , pp. 4396-4403
    • Weber, C.1    Boursaux-Eude, C.2    Coralie, G.3    Caro, V.4    Guiso, N.5
  • 9
    • 84905986587 scopus 로고    scopus 로고
    • Pertussis (Whooping Cough) Centers for Disease Control and Prevention. Atlanta, GA: CDC. Available from: [Last accessed 13 February 2014]
    • Pertussis (Whooping Cough) Clinical Implications Infants and Children. Centers for Disease Control and Prevention. Atlanta, GA: CDC. Available from: www.cdc.gov/pertussis/clinical/complications.html [Last accessed 13 February 2014]
    • Clinical Implications Infants and Children
  • 10
    • 80755138410 scopus 로고    scopus 로고
    • Clinical and laboratory features of pertussis in infants at the onset of a California epidemic
    • Nieves DJ, Singh J, Ashouri N, et al. Clinical and laboratory features of pertussis in infants at the onset of a California epidemic. J Pediatr 2011;159(6):1044-6
    • (2011) J Pediatr , vol.159 , Issue.6 , pp. 1044-1046
    • Nieves, D.J.1    Singh, J.2    Ashouri, N.3
  • 11
    • 17444421538 scopus 로고    scopus 로고
    • Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies
    • DOI 10.1128/CMR.18.2.326-382.2005
    • Mattoo S, Cherry JD. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev 2005;18(2): 326-82 (Pubitemid 40548297)
    • (2005) Clinical Microbiology Reviews , vol.18 , Issue.2 , pp. 326-382
    • Mattoo, S.1    Cherry, J.D.2
  • 13
    • 84905980496 scopus 로고    scopus 로고
    • American Academy of Pediatrics. California. Available from Last accessed 1 May 2014
    • Pertussis in Young Infants. American Academy of Pediatrics. California. Available from: www.aap-ca.org/clinical/pertussis/pertussis-in-young-infants. html [Last accessed 1 May 2014]
    • Pertussis in Young Infants
  • 14
    • 76749144149 scopus 로고    scopus 로고
    • Clinical characteristics and outcomes of neonatal pertussis: A comparative study
    • Castagnini LA, Munoz FM. Clinical characteristics and outcomes of neonatal pertussis: a comparative study. J Pediatr 2010;156(3):498-500
    • (2010) J Pediatr , vol.156 , Issue.3 , pp. 498-500
    • Castagnini, L.A.1    Munoz, F.M.2
  • 16
    • 78649716905 scopus 로고    scopus 로고
    • Prevalence of Bordetella pertussis and Bordetella parapertussis in samples submitted for RSV screening
    • Walsh P, Overmeyer C, Kimmel L, et al. Prevalence of Bordetella pertussis and Bordetella parapertussis in samples submitted for RSV screening. West J Emerg Med 2008;9(3):135-40
    • (2008) West J Emerg Med , vol.9 , Issue.3 , pp. 135-140
    • Walsh, P.1    Overmeyer, C.2    Kimmel, L.3
  • 17
    • 0031547545 scopus 로고    scopus 로고
    • Case definitions for infectious conditions under public health surveillance
    • Centers for Disease Control and Prevention
    • Case definitions for infectious conditions under public health surveillance. Centers for Disease Control and Prevention. MMWR Recomm Rep 1997;46(RR-10)):1-55
    • (1997) MMWR Recomm Rep , vol.46 RR-10 , pp. 1-55
  • 20
    • 0032789201 scopus 로고    scopus 로고
    • Comparison of PCR, culture, and direct fluorescent-antibody testing for detection of Bordetella pertussis
    • Loeffelholz MJ, Thompson CJ, Long KS, Gilchrist MJ. Comparison of PCR, culture, and direct fluorescent-antibody testing for detection of Bordetella pertussis. J Clin Microbiol 1999;37(9):2872-6 (Pubitemid 29391902)
    • (1999) Journal of Clinical Microbiology , vol.37 , Issue.9 , pp. 2872-2876
    • Loeffelholz, M.J.1    Thompson, C.J.2    Long, K.S.3    Gilchrist, M.J.R.4
  • 22
    • 34548423655 scopus 로고    scopus 로고
    • Outbreaks of respiratory illness mistakenly attributed to pertussis-New Hampshire, Massachusetts, and Tennessee 2004 2006
    • Outbreaks of respiratory illness mistakenly attributed to pertussis-New Hampshire, Massachusetts, and Tennessee, 2004-2006. MMWR Morb Mortal Wkly Rep 2007; 56(33):837-42
    • (2007) MMWR Morb Mortal Wkly Rep , vol.56 , Issue.33 , pp. 837-842
  • 23
    • 84856521406 scopus 로고    scopus 로고
    • Pertussis Pseudo-outbreak linked to specimens contaminated by Bordetella pertussis DNA from clinic surfaces
    • Mandal S, Tatti KM, Woods-Stout D, et al. Pertussis Pseudo-outbreak linked to specimens contaminated by Bordetella pertussis DNA From clinic surfaces. Pediatrics 2012;129(2):e424-30
    • (2012) Pediatrics , vol.129 , Issue.2
    • Mandal, S.1    Tatti, K.M.2    Woods-Stout, D.3
  • 24
    • 84901023266 scopus 로고    scopus 로고
    • Bordetella holmesii: An under-recognised Bordetella species
    • Pittet LF, Emonet S, Schrenzel J, et al. Bordetella holmesii: an under-recognised Bordetella species. Lancet Infect Dis 2014; 14(6):510-19
    • (2014) Lancet Infect Dis , vol.14 , Issue.6 , pp. 510-519
    • Pittet, L.F.1    Emonet, S.2    Schrenzel, J.3
  • 25
    • 84874478441 scopus 로고    scopus 로고
    • Bordetella holmesii in children suspected of pertussis in Argentina
    • Bottero D, Griffith MM, Lara C, et al. Bordetella holmesii in children suspected of pertussis in Argentina. Epidemiol Infect 2013;141(4):714-17
    • (2013) Epidemiol Infect , vol.141 , Issue.4 , pp. 714-717
    • Bottero, D.1    Griffith, M.M.2    Lara, C.3
  • 26
    • 84905987959 scopus 로고    scopus 로고
    • Recommended antimicrobial agents for the treatment and postexposure prophylaxis of pertussis 2005 guidelines
    • Atlanta, GA: CDC. Available from [Last accessed 9 December 2005]
    • Recommended antimicrobial agents for the treatment and postexposure prophylaxis of pertussis 2005 guidelines. Centers for Disease Control and Prevention. Atlanta, GA: CDC. Available from: www.cdc.gov/mmwr/preview/mmwrhtml/ rr5414a1 [Last accessed 9 December 2005]
    • Centers for Disease Control and Prevention
  • 27
    • 33644620484 scopus 로고    scopus 로고
    • Recommended antimicrobial agents for the treatment and postexposure prophylaxis of pertussis: 2005 CDC Guidelines
    • Tiwari T, Murphy TV, Moran J. Recommended antimicrobial agents for the treatment and postexposure prophylaxis of pertussis: 2005 CDC Guidelines. MMWR Recomm Rep 2005;54(RR-14)):1-16
    • (2005) MMWR Recomm Rep , vol.54 RR-14 , pp. 1-16
    • Tiwari, T.1    Murphy, T.V.2    Moran, J.3
  • 29
    • 84877731671 scopus 로고    scopus 로고
    • Critical pertussis illness in children: A multicenter prospective cohort study
    • Berger JT, Carcillo JA, Shanley TP, et al. Critical pertussis illness in children: a multicenter prospective cohort study. Pediatr Crit Care Med 2013;14(4):356-65
    • (2013) Pediatr Crit Care Med , vol.14 , Issue.4 , pp. 356-365
    • Berger, J.T.1    Carcillo, J.A.2    Shanley, T.P.3
  • 30
    • 40949111955 scopus 로고    scopus 로고
    • Pertussis hospitalizations among infants in the United States 1993 to 2004
    • Cortese MM, Baughman AL, Zhang R, et al. Pertussis hospitalizations among infants in the United States, 1993 to 2004. Pediatrics 2008;121(3):484-92
    • (2008) Pediatrics , vol.121 , Issue.3 , pp. 484-492
    • Cortese, M.M.1    Baughman, A.L.2    Zhang, R.3
  • 31
    • 49349109152 scopus 로고    scopus 로고
    • Poor immune responses to a birth dose of diphtheria, tetanus, and acellular pertussis vaccine
    • Halasa NB, O'Shea A, Shi JR, et al. Poor immune responses to a birth dose of diphtheria, tetanus, and acellular pertussis vaccine. J Pediatr 2008;153(3):327-32
    • (2008) J Pediatr , vol.153 , Issue.3 , pp. 327-332
    • Halasa, N.B.1    O'Shea, A.2    Shi, J.R.3
  • 32
    • 0001417538 scopus 로고
    • Immunization and antibody response in the newborn infant. I. Pertussis inoculation within twenty-four hours of birth
    • Provenzano RW, Wetterlow LH, Sullivan CL. Immunization and antibody response in the newborn infant. I. Pertussis inoculation within twenty-four hours of birth. N Engl J Med 1965;273(18):959-65
    • (1965) N Engl J Med , vol.273 , Issue.18 , pp. 959-965
    • Provenzano, R.W.1    Wetterlow, L.H.2    Sullivan, C.L.3
  • 33
    • 41849112305 scopus 로고    scopus 로고
    • Neonatal vaccination with an acellular pertussis vaccine accelerates the acquisition of pertussis antibodies in infants
    • 660 e651
    • Knuf M, Schmitt HJ, Wolter J, et al. Neonatal vaccination with an acellular pertussis vaccine accelerates the acquisition of pertussis antibodies in infants. J Pediatr 2008;152(5):655-60.660 e651
    • (2008) J Pediatr , vol.152 , Issue.5 , pp. 655-660
    • Knuf, M.1    Schmitt, H.J.2    Wolter, J.3
  • 34
    • 77949472573 scopus 로고    scopus 로고
    • Booster vaccination after neonatal priming with acellular pertussis vaccine
    • Knuf M, Schmitt HJ, Jacquet JM, et al. Booster vaccination after neonatal priming with acellular pertussis vaccine. J Pediatr 2010;156(4):675-8
    • (2010) J Pediatr , vol.156 , Issue.4 , pp. 675-678
    • Knuf, M.1    Schmitt, H.J.2    Jacquet, J.M.3
  • 37
    • 84871931831 scopus 로고    scopus 로고
    • Sources of pertussis infection in young infants: A review of key evidence informing targeting of the cocoon strategy
    • Wiley KE, Zuo Y, Macartney KK, McIntyre PB. Sources of pertussis infection in young infants: a review of key evidence informing targeting of the cocoon strategy. Vaccine 2013;31(4):618-25
    • (2013) Vaccine , vol.31 , Issue.4 , pp. 618-625
    • Wiley, K.E.1    Zuo, Y.2    MacArtney, K.K.3    McIntyre, P.B.4
  • 38
    • 84925549068 scopus 로고    scopus 로고
    • Preventing tetanus, diphtheria, and pertussis among adults: Use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel
    • Kretsinger K, Broder KR, Cortese MM, et al. Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel. MMWR. Recomm Rep 2006;55(RR-17): 1-37
    • (2006) MMWR. Recomm Rep , vol.55 RR-17 , pp. 1-37
    • Kretsinger, K.1    Broder, K.R.2    Cortese, M.M.3
  • 39
    • 84888428947 scopus 로고    scopus 로고
    • Evaluation of several approaches to immunize parents of neonates against B pertussis
    • Frere J, De Wals P, Ovetchkine P, et al. Evaluation of several approaches to immunize parents of neonates against B. pertussis. Vaccine 2013;31(51):6087-91
    • (2013) Vaccine , vol.31 , Issue.51 , pp. 6087-6091
    • Frere, J.1    De Wals, P.2    Ovetchkine, P.3
  • 40
    • 70249093662 scopus 로고    scopus 로고
    • Cocooning infants: Tdap immunization for new parents in the pediatric office
    • Walter EB, Allred N, Rowe-West B, et al. Cocooning infants: Tdap immunization for new parents in the pediatric office. Acad Pediatr 2009;9(5):344-7
    • (2009) Acad Pediatr , vol.9 , Issue.5 , pp. 344-347
    • Walter, E.B.1    Allred, N.2    Rowe-West, B.3
  • 41
    • 84880335381 scopus 로고    scopus 로고
    • A cross sectional survey of attitudes, awareness and uptake of the parental pertussis booster vaccine as part of a cocooning strategy, Victoria, Australia
    • Donnan EJ, Fielding JE, Rowe SL, et al. A cross sectional survey of attitudes, awareness and uptake of the parental pertussis booster vaccine as part of a cocooning strategy, Victoria, Australia. BMC Public Health 2013;13:676
    • (2013) BMC Public Health , vol.13 , pp. 676
    • Donnan, E.J.1    Fielding, J.E.2    Rowe, S.L.3
  • 42
    • 84899936445 scopus 로고    scopus 로고
    • Engaging Expectant Parents to Receive Tdap Vaccination
    • Steiner B, Swamy GK, Walter EB. Engaging Expectant Parents to Receive Tdap Vaccination. Am J Perinatol 2013; 31(5):407-12
    • (2013) Am J Perinatol , vol.31 , Issue.5 , pp. 407-412
    • Steiner, B.1    Swamy, G.K.2    Walter, E.B.3
  • 43
    • 84878737597 scopus 로고    scopus 로고
    • Pregnancy dose Tdap and postpartum cocooning to prevent infant pertussis: A decision analysis
    • Terranella A, Asay GR, Messonnier ML, et al. Pregnancy dose Tdap and postpartum cocooning to prevent infant pertussis: a decision analysis. Pediatrics 2013;131(6): e1748-56
    • (2013) Pediatrics , vol.131 , Issue.6
    • Terranella, A.1    Asay, G.R.2    Messonnier, M.L.3
  • 44
    • 77955904727 scopus 로고    scopus 로고
    • Cost-effectiveness analysis of various pertussis vaccination strategies primarily aimed at protecting infants in the Netherlands
    • Westra TA, de Vries R, Tamminga JJ, et al. Cost-effectiveness analysis of various pertussis vaccination strategies primarily aimed at protecting infants in the Netherlands. Clin Ther 2010;32(8):1479-95
    • (2010) Clin Ther , vol.32 , Issue.8 , pp. 1479-1495
    • Westra, T.A.1    De Vries, R.2    Tamminga, J.J.3
  • 45
    • 84873085298 scopus 로고    scopus 로고
    • Cocoon" immunization to prevent pertussis-related hospitalization in infants: The case of Piemonte in Italy
    • Meregaglia M, Ferrara L, Melegaro A, Demicheli V. Parent "cocoon" immunization to prevent pertussis-related hospitalization in infants: the case of Piemonte in Italy. Vaccine 2013;31(8): 1135-7
    • (2013) Vaccine , vol.31 , Issue.8 , pp. 1135-1137
    • Meregaglia, M.1    Ferrara, L.2    Melegaro, A.3    Parent, D.V.4
  • 46
    • 84886100248 scopus 로고    scopus 로고
    • Cost-effectiveness of targeted vaccination to protect newborns against pertussis: Comparing neonatal maternal and cocooning vaccination strategies
    • Lugner AK, van der Maas N, van Boven M, et al. Cost-effectiveness of targeted vaccination to protect newborns against pertussis: comparing neonatal, maternal, and cocooning vaccination strategies. Vaccine 2013;31(46):5392-7
    • (2013) Vaccine , vol.31 , Issue.46 , pp. 5392-5397
    • Lugner, A.K.1    Van Der Maas, N.2    Van Boven, M.3
  • 47
    • 84893597571 scopus 로고    scopus 로고
    • A cocoon immunisation strategy against pertussis for infants: Does it make sense for Ontario?
    • Lim GH, Deeks SL, Crowcroft NS. A cocoon immunisation strategy against pertussis for infants: does it make sense for Ontario? Euro Surveill 2014;19:5
    • (2014) Euro Surveill , vol.19 , pp. 5
    • Lim, G.H.1    Deeks, S.L.2    Crowcroft, N.S.3
  • 48
    • 84555209272 scopus 로고    scopus 로고
    • Impact of maternal postpartum tetanus and diphtheria toxoids and acellular pertussis immunization on infant pertussis infection
    • Castagnini LA, Healy CM, Rench MA, et al. Impact of maternal postpartum tetanus and diphtheria toxoids and acellular pertussis immunization on infant pertussis infection. Clin Infect Dis 2012;54(1):78-84
    • (2012) Clin Infect Dis , vol.54 , Issue.1 , pp. 78-84
    • Castagnini, L.A.1    Healy, C.M.2    Rench, M.A.3
  • 49
    • 80054824104 scopus 로고    scopus 로고
    • Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) in pregnant women and persons who have or anticipate having close contact with an infant aged 12 months-Advisory Committee on Immunization Practices (ACIP), 2011
    • Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) in pregnant women and persons who have or anticipate having close contact with an infant aged
    • (2011) MMWR Morb Mortal Wkly Rep , vol.60 , Issue.41 , pp. 1424-1426
  • 50
    • 53749099143 scopus 로고    scopus 로고
    • Effectiveness of maternal influenza immunization in mothers and infants
    • Zaman K, Roy E, Arifeen SE, et al. Effectiveness of maternal influenza immunization in mothers and infants. N Engl J Med 2008;359(15):1555-64
    • (2008) N Engl J Med , vol.359 , Issue.15 , pp. 1555-1564
    • Zaman, K.1    Roy, E.2    Arifeen, S.E.3
  • 51
    • 79952682705 scopus 로고    scopus 로고
    • Maternal immunization with tetanus-diphtheria-pertussis vaccine: Effect on maternal and neonatal serum antibody levels
    • Gall SA, Myers J, Pichichero M. Maternal immunization with tetanus-diphtheria-pertussis vaccine: effect on maternal and neonatal serum antibody levels. Am J Obstet Gynecol 2011;204(4): 334-e331-5
    • (2011) Am J Obstet Gynecol , vol.204 , Issue.4
    • Gall, S.A.1    Myers, J.2    Pichichero, M.3
  • 52
    • 84905987180 scopus 로고    scopus 로고
    • Meeting of the Advisory Committee on Immunization Practices (ACIP) Summary report Available from Last accessed 28 February 2014
    • Meeting of the Advisory Committee on Immunization Practices (ACIP) Summary report. Available from: www.cdc.gov/vaccines/acip/meetings/minutes- archive.html Last accessed 28 February 2014]
  • 53
    • 84905984729 scopus 로고    scopus 로고
    • CDC Advisory Committee for Immunization Practices Recommends Tdap immunization for pregnant women. center for disease control and prevention press release. Available from [Last accessed 23 October 2012]
    • CDC Advisory Committee for Immunization Practices Recommends Tdap immunization for pregnant women. center for disease control and prevention press release. Available from: www.cdc.gov/media/releases/2012/a1024-Tdap- immunization. html [Last accessed 23 October 2012]
  • 54
    • 84873038397 scopus 로고    scopus 로고
    • Importance of timing of maternal combined tetanus, diphtheria, and acellular pertussis (Tdap) immunization and protection of young infants
    • Healy CM, Rench MA, Baker CJ. Importance of timing of maternal combined tetanus, diphtheria, and acellular pertussis (Tdap) immunization and protection of young infants. Clin Infect Dis 2013;56(4): 539-44
    • (2013) Clin Infect Dis , vol.56 , Issue.4 , pp. 539-544
    • Healy, C.M.1    Rench, M.A.2    Baker, C.J.3
  • 55
    • 84905987777 scopus 로고    scopus 로고
    • ACOG Committee Opinion 56: update on Immunization and Pregnancy: tetanus, diptheria and pertussis vaccination. American College of Obstetrics and Gynecology. Available from Last accessed June 2013
    • ACOG Committee Opinion 56: update on Immunization and Pregnancy: tetanus, diptheria and pertussis vaccination. American College of Obstetrics and Gynecology. Available from: www.ncbi.nlm. nih.gov/entrez/query.fcgi? cmd=Retrieve&db=PubMed&dopt= Citation&list-uids=23812487 [Last accessed June 2013]
  • 56
    • 84876000191 scopus 로고    scopus 로고
    • Reduced risk of pertussis among persons ever vaccinated with whole cell pertussis vaccine compared to recipients of acellular pertussis vaccines in a large US cohort
    • Witt MA, Arias L, Katz PH, et al. Reduced risk of pertussis among persons ever vaccinated with whole cell pertussis vaccine compared to recipients of acellular pertussis vaccines in a large US cohort. Clin Infect Dis 2013;56(9):1248-54
    • (2013) Clin Infect Dis , vol.56 , Issue.9 , pp. 1248-1254
    • Witt, M.A.1    Arias, L.2    Katz, P.H.3
  • 57
    • 84880873432 scopus 로고    scopus 로고
    • Effectiveness of pertussis vaccines for adolescents and adults: Case-control study
    • Baxter R, Bartlett J, Rowhani-Rahbar A, et al. Effectiveness of pertussis vaccines for adolescents and adults: case-control study. BMJ 2013;347:f4249
    • (2013) BMJ , vol.347
    • Baxter, R.1    Bartlett, J.2    Rowhani-Rahbar, A.3
  • 60
    • 54449093962 scopus 로고    scopus 로고
    • Vaccines for pertussis and influenza: Recommendations for use in pregnancy
    • Gall SA. Vaccines for pertussis and influenza: recommendations for use in pregnancy. Clin Obstet Gynecol 2008; 51(3):486-97
    • (2008) Clin Obstet Gynecol , vol.51 , Issue.3 , pp. 486-497
    • Gall, S.A.1
  • 61
    • 84860304958 scopus 로고    scopus 로고
    • Prevention of pertussis tetanus and diphtheria among pregnant postpartum women and infants
    • Gall SA. Prevention of pertussis, tetanus, and diphtheria among pregnant, postpartum women, and infants. Clin Obstet Gynecol 2012;55(2):498-509
    • (2012) Clin Obstet Gynecol , vol.55 , Issue.2 , pp. 498-509
    • Gall, S.A.1
  • 62
    • 0037484129 scopus 로고    scopus 로고
    • Mechanisms by which maternal antibodies influence infant vaccine responses: Review of hypotheses and definition of main determinants
    • Siegrist CA. Mechanisms by which maternal antibodies influence infant vaccine responses: review of hypotheses and definition of main determinants. Vaccine 2003;21(24):3406-12
    • (2003) Vaccine , vol.21 , Issue.24 , pp. 3406-3412
    • Siegrist, C.A.1
  • 63
    • 84886947052 scopus 로고    scopus 로고
    • Immune responses in infants whose mothers received Tdap vaccine during pregnancy
    • Hardy-Fairbanks AJ, Pan SJ, Decker MD, et al. Immune responses in infants whose mothers received Tdap vaccine during pregnancy. Pediatr Infect Dis J 2013; 32(11):1257-60
    • (2013) Pediatr Infect Dis J , vol.32 , Issue.11 , pp. 1257-1260
    • Hardy-Fairbanks, A.J.1    Pan, S.J.2    Decker, M.D.3
  • 64
    • 84899886515 scopus 로고    scopus 로고
    • Safety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunization during pregnancy in mothers and infants: A randomized clinical tria
    • Munoz FM, Bond NH, Maccato M, et al. Safety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunization during pregnancy in mothers and infants: a randomized clinical trial. JAMA 2014;311(17):1760-9
    • (2014) JAMA , vol.311 , Issue.17 , pp. 1760-1769
    • Munoz, F.M.1    Bond, N.H.2    MacCato, M.3
  • 65
    • 84862567807 scopus 로고    scopus 로고
    • Recommended immunization schedule for the persons aged 0 through 18 years-United States, 2012
    • CD
    • CDC. Recommended immunization schedule for the persons aged 0 through 18 years-United States, 2012. MMWR Morb Mortal Wkly Rep 2012;61(4):66-72
    • (2012) MMWR Morb Mortal Wkly Rep , vol.61 , Issue.4 , pp. 66-72
  • 66
    • 84862688726 scopus 로고    scopus 로고
    • Adverse event reports after tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccines in pregnant women
    • Zheteyeva YA, Moro PL, Tepper NK, et al. Adverse event reports after tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccines in pregnant women. Am J Obstet Gynecol 2012;207(1):59-e51-7
    • (2012) Am J Obstet Gynecol , vol.207 , Issue.1
    • Zheteyeva, Y.A.1    Moro, P.L.2    Tepper, N.K.3
  • 67
    • 78650243149 scopus 로고    scopus 로고
    • The safety of immunizing with tetanus-diphtheria-acellular pertussis vaccine (Tdap) less than 2 years following previous tetanus vaccination: Experience during a mass vaccination campaign of healthcare personnel during a respiratory illness outbreak
    • Talbot EA, Brown KH, Kirkland KB, et al. The safety of immunizing with tetanus-diphtheria-acellular pertussis vaccine (Tdap) less than 2 years following previous tetanus vaccination: experience during a mass vaccination campaign of healthcare personnel during a respiratory illness outbreak. Vaccine 2010;28(50):8001-7
    • (2010) Vaccine , vol.28 , Issue.50 , pp. 8001-8007
    • Talbot, E.A.1    Brown, K.H.2    Kirkland, K.B.3
  • 68
    • 84892640386 scopus 로고    scopus 로고
    • Attenuated Bordetella pertussis vaccine protects against respiratory syncytial virus disease via an IL-17-dependent mechanism
    • Schnoeller C, Roux X, Sawant D, et al. Attenuated Bordetella pertussis vaccine protects against respiratory syncytial virus disease via an IL-17-dependent mechanism. Am J Respir Crit Care Med 2014;189(2): 194-202
    • (2014) Am J Respir Crit Care Med , vol.189 , Issue.2 , pp. 194-202
    • Schnoeller, C.1    Roux, X.2    Sawant, D.3
  • 69
    • 84867259382 scopus 로고    scopus 로고
    • Influenza vaccination coverage among pregnant women: 2011-12 influenza season United States
    • Influenza vaccination coverage among pregnant women: 2011-12 influenza season, United States. MMWR Morb Mortal Wkly Rep 2012;61:758-63
    • (2012) MMWR Morb Mortal Wkly Rep , vol.61 , pp. 758-763
  • 70
    • 75849124774 scopus 로고    scopus 로고
    • Safety Study of Respiratory Syncytial Virus (RSV)-Fusion (F) Protein Particle Vaccine gov Available from [Last accessed 2 January 2014]
    • Safety Study of Respiratory Syncytial Virus (RSV)-Fusion (F) Protein Particle Vaccine. ClinicalTrials.gov Available from: http://clinicaltrials.gov/ show/NCT01290419 [Last accessed 2 January 2014]
    • Clinical Trials
  • 71
    • 84905978891 scopus 로고    scopus 로고
    • Immune response induced by a vaccine against group B streptococcus and safety in pregnant women and their offsprings
    • gov Available from [Last accessed 2 January 2014]
    • Immune response induced by a vaccine against group B streptococcus and safety in pregnant women and their offsprings. ClinicalTrials.gov Available from: http://clinicaltrials.gov/show/NCT01446289 [Last accessed 2 January 2014]
    • Clinical Trial


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.